Dateline City:
MADISON, N.J.
Topical Treatment for Fleas and Ticks Effective for up to 12 Weeks
MADISON, N.J.--(BUSINESS WIRE)--Merck Animal Health, known as MSD Animal Health outside of the United
States and Canada, today announced the U.S. Food and Drug
Administrations approval of BRAVECTO (fluralaner topical
solution) for both cats and dogs, a topical treatment for fleas and
ticks effective for up to 12 weeks1,2 following a single dose.
Language:
English
Contact:
Merck Animal HealthMedia:Kelly Goss, 913-558-6452 kelly.goss@merck.com orPamela Eisele, 267-305-3558 pamela.eisele@merck.com orInvestor Relations:Amy Klug, 908-740-1898 amy.klug@merck.com
Ticker Slug:
Ticker: MRK Exchange: NYSE
read more